HilleVax (HLVX)
(Real Time Quote from BATS)
$1.80 USD
0.00 (0.00%)
Updated Sep 23, 2024 09:58 AM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for HilleVax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -123.57 | -159.81 | -102.41 | NA | NA |
Depreciation/Amortization & Depletion | -0.20 | 0.29 | 0.00 | NA | NA |
Net Change from Assets/Liabilities | 22.84 | -5.40 | 11.28 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 14.14 | 102.93 | 83.84 | NA | NA |
Net Cash From Operating Activities | -86.78 | -61.99 | -7.30 | NA | NA |
Property & Equipment | -10.75 | -6.51 | -2.81 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | -83.89 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | -94.64 | -6.51 | -2.81 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 108.90 | 230.01 | 0.00 | NA | NA |
Issuance (Repayment) of Debt | 9.80 | 14.67 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 135.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | 0.00 | -19.70 | -0.79 | NA | NA |
Net Cash from Financing Activities | 118.70 | 224.97 | 134.21 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -62.72 | 156.47 | 124.11 | NA | NA |
Cash at Beginning of Period | 281.03 | 124.57 | 0.46 | NA | NA |
Cash at End of Period | 218.31 | 281.03 | 124.57 | NA | NA |
Diluted Net EPS | -3.04 | -5.89 | -18.22 | NA | NA |
Fiscal Year End for HilleVax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -87.50 | -46.83 | -123.57 | -86.61 | -54.79 |
Depreciation/Amortization & Depletion | -0.97 | -0.43 | -0.20 | -0.03 | 0.43 |
Net Change from Assets/Liabilities | -9.48 | -6.43 | 22.84 | 11.25 | 9.90 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 35.17 | 20.69 | 14.14 | 10.21 | 6.09 |
Net Cash From Operating Activities | -62.78 | -33.00 | -86.78 | -65.18 | -38.37 |
Property & Equipment | -14.03 | -13.98 | -10.75 | -10.01 | -7.82 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -47.11 | -43.68 | -83.89 | -114.10 | -85.11 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -61.13 | -57.66 | -94.64 | -124.11 | -92.93 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.79 | 15.06 | 108.90 | 108.59 | 0.48 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 9.80 | 9.80 | 9.80 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 14.89 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 15.68 | 15.06 | 118.70 | 118.39 | 10.28 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -108.23 | -75.60 | -62.72 | -70.90 | -121.03 |
Cash at Beginning of Period | 218.31 | 218.31 | 281.03 | 281.03 | 281.03 |
Cash at End of Period | 110.08 | 142.71 | 218.31 | 210.13 | 160.01 |
Diluted Net EPS | -0.83 | -0.97 | -0.78 | -0.81 | -0.74 |